Myung-Haing Cho Selected Research

poly(caprolactone-block-ethyleneimine)

7/2012	Kidney-specific peptide-conjugated poly(ester amine) for the treatment of kidney fibrosis.
7/2008	Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myung-Haing Cho Research Topics

Disease

59	Neoplasms (Cancer) 01/2022 - 01/2004
48	Lung Neoplasms (Lung Cancer) 06/2022 - 04/2006
23	Carcinogenesis 04/2017 - 09/2004
6	Fibrosis (Cirrhosis) 03/2021 - 12/2004
6	Inflammation (Inflammations) 01/2017 - 06/2008
6	Neoplasm Metastasis (Metastasis) 01/2017 - 03/2009
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2010
4	Liver Neoplasms (Liver Cancer) 03/2021 - 02/2012
4	Body Weight (Weight, Body) 01/2017 - 03/2006
3	Non-alcoholic Fatty Liver Disease 03/2021 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 12/2017 - 12/2015
3	Adenocarcinoma 01/2015 - 03/2008
3	Breast Neoplasms (Breast Cancer) 07/2012 - 12/2010
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 01/2003
2	Obesity 03/2021 - 05/2016
2	Insulin Resistance 12/2017 - 12/2015
2	Asthma (Bronchial Asthma) 12/2016 - 11/2013
2	Hypersensitivity (Allergy) 04/2016 - 01/2012
2	Lung Diseases (Lung Disease) 01/2016 - 11/2006
2	Hepatocellular Carcinoma (Hepatoma) 06/2015 - 01/2012
2	Edema (Dropsy) 06/2014 - 10/2008
2	Brain Neoplasms (Brain Tumor) 06/2012 - 04/2011
2	Carcinoma (Carcinomatosis) 05/2012 - 07/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2021
1	Liver Diseases (Liver Disease) 03/2021
1	Liver Failure 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021

Drug/Important Bio-Agent (IBA)

22	AerosolsIBA 01/2022 - 04/2006
19	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2008
17	Proteins (Proteins, Gene)FDA Link 12/2016 - 10/2006
8	Phosphates (Orthophosphate)IBA 02/2015 - 03/2006
6	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 10/2009
6	SpermineIBA 04/2017 - 11/2011
6	OsteopontinIBA 08/2015 - 12/2010
5	PolyethyleneimineIBA 01/2016 - 11/2005
4	LipidsIBA 01/2018 - 05/2016
4	Therapeutic UsesIBA 04/2017 - 03/2010
4	ProdrugsIBA 12/2015 - 09/2009
4	ChitosanIBA 12/2015 - 07/2006
4	Ethylene Glycol (Monoethylene Glycol)IBA 07/2014 - 06/2008
3	Sorbitol (Yal)FDA Link 01/2022 - 08/2015
3	Glycerol (Glycerine)FDA LinkGeneric 04/2017 - 01/2012
3	RNA (Ribonucleic Acid)IBA 04/2017 - 01/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2017 - 11/2009
3	CytokinesIBA 12/2016 - 05/2005
3	Glucose (Dextrose)FDA LinkGeneric 05/2016 - 11/2005
3	LC15-0444IBA 12/2015 - 12/2014
3	chitosan-graft-polyethylenimineIBA 01/2013 - 08/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 11/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2012 - 09/2009
3	Urethane (Ethyl Carbamate)IBA 10/2009 - 07/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022 - 01/2010
2	FructoseIBA 03/2021 - 12/2017
2	CollagenIBA 03/2021 - 06/2014
2	Peptides (Polypeptides)IBA 01/2020 - 07/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2010
2	MicroRNAs (MicroRNA)IBA 04/2019 - 11/2010
2	SmokeIBA 12/2017 - 01/2016
2	CarcinogensIBA 04/2017 - 03/2011
2	LeptinIBA 01/2017 - 05/2016
2	Lithocholic AcidIBA 01/2017 - 06/2015
2	AntioxidantsIBA 12/2016 - 01/2012
2	PesticidesIBA 12/2016 - 12/2014
2	Indicators and Reagents (Reagents)IBA 01/2016 - 12/2004
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016 - 07/2012
2	Blood Glucose (Blood Sugar)IBA 12/2015 - 08/2015
2	EnzymesIBA 08/2015 - 04/2011
2	Antineoplastic Agents (Antineoplastics)IBA 03/2015 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 09/2013
2	SodiumIBA 01/2014 - 01/2013
2	SymportersIBA 01/2014 - 01/2013
2	Beclin-1IBA 09/2013 - 07/2012
2	Hormones (Hormone)IBA 01/2013 - 03/2005
2	EstersIBA 07/2012 - 11/2011
2	poly(caprolactone-block-ethyleneimine)IBA 07/2012 - 07/2008
2	cyclic 3',5'-thymidine monophosphate (cTMP)IBA 05/2012 - 06/2009
2	HydrogelsIBA 03/2012 - 09/2009
2	Conjugated Linoleic AcidsIBA 03/2012 - 09/2009
2	Poloxamer (Poloxamer 407)IBA 03/2012 - 09/2009
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2011 - 11/2010
2	polycaprolactoneIBA 05/2010 - 03/2010
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 10/2008 - 06/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 05/2005
2	7-hydroxy-3-methoxy-cadaleneIBA 01/2007 - 09/2004
2	Estrogens (Estrogen)FDA Link 03/2005 - 10/2004
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2022
1	glucose-regulated proteinsIBA 06/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2021
1	peptide AIBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2018

Therapy/Procedure

26	Therapeutics 01/2020 - 04/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 11/2009
5	Radiotherapy 01/2022 - 11/2009
4	Immunotherapy 01/2022 - 07/2006
3	Oral Administration 06/2014 - 01/2005
2	Intraperitoneal Injections 04/2017 - 12/2015
2	Intravenous Injections 08/2015 - 02/2012
2	Photothermal Therapy 07/2015 - 03/2015